We evaluated SGLT1 expression in patients with DCM, examined the effect of SGLT1 inhibition on the development of DCM, and investigated whether SGLT1 works through the JNK and p38 pathway. This evidence concerns the gene MAPK14 and familial dilated cardiomyopathy.